Valge-Archer; Viia
Patent Applications and Registrations
Patent applications and USPTO patent grants for Valge-Archer; Viia.The latest application filed is for "neutralizing antibodies against gdf-8 and uses therefor".
- Valge-Archer; Viia - Little Abington GB
- Valge-Archer; Viia - Cambridge N/A GB
- Valge-Archer; Viia - Little Abbington GB
- Valge-Archer; Viia - Cambs GB
| Patent | Date |
|---|---|
| Neutralizing antibodies against GDF-8 and uses therefor Grant 8,940,874 - Veldman , et al. January 27, 2 | 2015-01-27 |
| Neutralizing Antibodies Against Gdf-8 And Uses Therefor App 20130287762 - Veldman; Geetruida M. ; et al. | 2013-10-31 |
| Nucleic acid encoding antibody to human IL-22 Grant 8,470,993 - Gill , et al. June 25, 2 | 2013-06-25 |
| Neutralizing antibodies against GDF-8 and uses therefor Grant 8,420,082 - Veldman , et al. April 16, 2 | 2013-04-16 |
| Antibodies To Human Il-22 App 20130005033 - Gill; Davinder S. ; et al. | 2013-01-03 |
| Interleukin-21 Receptor Binding Proteins App 20120264919 - BLOOM; Laird ; et al. | 2012-10-18 |
| Antibodies to human IL-22 Grant 8,187,603 - Gill , et al. May 29, 2 | 2012-05-29 |
| Antibodies to human IL-22 Grant 8,182,817 - Gill , et al. May 22, 2 | 2012-05-22 |
| Interleukin-21 receptor binding proteins Grant 8,163,884 - Bloom , et al. April 24, 2 | 2012-04-24 |
| Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor Grant 8,143,385 - Valge-Archer , et al. March 27, 2 | 2012-03-27 |
| Nucleic acids encoding antibodies against PD-1 Grant 8,088,905 - Collins , et al. January 3, 2 | 2012-01-03 |
| Antibodies Against Human IL-22 and Uses Therefor App 20110275790 - GILL; DAVINDER S. ; et al. | 2011-11-10 |
| Neutralizing Antibodies Against Gdf-8 And Uses Therefor App 20110243953 - Veldman; Geertruida M. ; et al. | 2011-10-06 |
| Antibodies against human IL-22 and uses therefor Grant 7,901,684 - Gill , et al. March 8, 2 | 2011-03-08 |
| Antibodies Against Human Il-21 Receptor And Uses Therefor App 20100297151 - Valge-Archer; Viia ; et al. | 2010-11-25 |
| Antibodies Against Human IL-22 And Uses Therefor App 20100184960 - Gill; Davinder S. ; et al. | 2010-07-22 |
| Neutralizing antibodies against GDF-8 and uses therefor Grant 7,655,763 - Veldman , et al. February 2, 2 | 2010-02-02 |
| Interleukin-21 Receptor Binding Proteins App 20090298167 - BLOOM; Laird ; et al. | 2009-12-03 |
| Methods of upmodulating adaptive immune response using anti-PD-1 antibodies Grant 7,521,051 - Collins , et al. April 21, 2 | 2009-04-21 |
| Antibodies against human or mouse IL-21 receptor Grant 7,495,085 - Valge-Archer , et al. February 24, 2 | 2009-02-24 |
| Antibodies against PD-1 and uses therefor App 20080311117 - Collins; Mary ; et al. | 2008-12-18 |
| Neutralizing Antibodies Against Gdf-8 And Uses Therefor App 20080044410 - Veldman; Geertruida M. ; et al. | 2008-02-21 |
| Antibodies against human IL-22 and uses therefor App 20070243589 - Gill; Davinder S. ; et al. | 2007-10-18 |
| Neutralizing antibodies against GDF-8 and uses therefor Grant 7,261,893 - Veldman , et al. August 28, 2 | 2007-08-28 |
| Antibodies against human IL-21 receptor and uses therefor App 20040265960 - Valge-Archer, Viia ; et al. | 2004-12-30 |
| Antibodies against PD-1 and uses therefor App 20040213795 - Collins, Mary ; et al. | 2004-10-28 |
| Neutralizing antibodies against GDF-8 and uses therefor App 20040142382 - Veldman, Geertruida M. ; et al. | 2004-07-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 